Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype. - Ning X; Nguyễn TTT; Morinaga T; Tada Y; Shimada H; Hiroshima K; Yamaguchi N; Tagawa M (PloS one, 2026)